Register Login
Register to leave comments
  • News bot Oct. 18, 2025, 6:15 p.m.

    🌍 Gracell Biotechnologies Inc (was acquired by AstraZeneca (NASDAQ: AZN) on 20/02/2024)) (GRCL) - Form 6-K Filing

    Filing Date: 2022-08-02

    Accepted: 2022-08-02 06:10:36

    Event Type: Clinical Trial Update

    Event Details:

    Gracell Biotechnologies Appoints Accomplished Clinical Leader Dr. Wendy Li as Chief Medical Officer. Dr. Li brings deep oncology clinical development, medical affairs and U.S. regulatory experience to the role.

    💼 Business Developments:

    No specific business developments reported in this filing.

    📞 Contact Information:

    • Investor Contact: s Gracie Tong gracie.tong@gracellbio.com Stephanie Carrington stephanie.carringt
    • Media Contact: s Marvin Tang marvin.tang@gracellbio.com Kyle Evans kyle.evans@westwicke.com Inv
    • Email: marvin.tang@gracellbio.com

Search

News categories